Skip to content
Medical Health Aged Care

Sharjah Emerges as a Global Hub for Medical Innovation and Collaborative R&D

Sharjah Research, Technology and Innovation Park 2 mins read
SHARJAH, United Arab Emirates--BUSINESS WIRE--

In the United Arab Emirates, where cities like Abu Dhabi and Dubai consistently rank among the world's most forward-thinking, the Emirate of Sharjah, the country's cultural and knowledge capital, has decisively positioned itself as a premier hub for research and innovations in healthcare. This transformation is primarily driven by the Sharjah Research, Technology and Innovation Park (SPARK) formerly SRTIP, SRTI Park.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118121763/en/

SPARK Headquarters (SPARK HQ) (Photo: AETOSWire)

SPARK Headquarters (SPARK HQ) (Photo: AETOSWire)

This ambition was powerfully demonstrated during the recent "Sharjah Next: Healthcare" forum, which transcended a typical conference, evolving into a powerful statement of intent. It assembled a host of global healthcare luminaries, including Professor Sir Magdi Yacoub, a pioneer in cardiothoracic surgery; Professor Humaid Obaid Al-Shamsi, a leading Emirati oncologist; and Dr. Vladimir Ivkovic of Harvard Medical School.

“With Sharjah Next: Healthcare, we created a global stage for dialogue, discovery, and collaboration,” commented Hussain Al Mahmoudi, CEO of SPARK. “Our aim is to connect international expertise with local opportunity, ensuring that innovation in Sharjah translates into lasting health and wellbeing for communities everywhere.”

The forum mirrored SPARK's core mission: to bridge the gap between groundbreaking laboratory research and real-world applications. The discussions delved into frontiers of neuroscience, AI-driven diagnostics, space medicine, and biotechnology, creating a unique networking platform for academics, clinicians, startups, and policymakers.

A resounding endorsement of this ecosystem came from HH Sheikh Dr. Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, who announced a $2 million grant to the revolutionary "Magdi Yacoub Valve" project. This pioneering technology, which allows a patient's body to grow a living heart valve, exemplifies the type of transformative research SPARK is designed to nurture.

SPARK’s model is fundamentally built on a robust triple-helix framework of collaboration between government, industry, and academia. New partnerships signed at the forum included an MOU with Boehringer Ingelheim to provide SPARK researchers access to its open-innovation platform, 'OpnME', and a master research agreement with Aster DM Healthcare to fast-track the development of medical technologies and AI in diagnostics.

These collaborations underscore a key value proposition for investors and researchers: SPARK is more than a physical park; it is an integrated ecosystem offering facilities like the SoiLab prototyping and manufacturing hub, streamlined regulatory support, and access to international partners and funding opportunities.

About Sharjah Research, Technology and Innovation Park (SPARK)

Source: AETOSWire


Contact details:

Yacoub Al Tahtamouni
[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.